Belvedere Trading LLC Summit Therapeutics Inc. Transaction History
Belvedere Trading LLC
- $82.2 Billion
- Q4 2024
A detailed history of Belvedere Trading LLC transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Belvedere Trading LLC holds 14,900 shares of SMMT stock, worth $267,157. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,900
Previous 1,548
862.53%
Holding current value
$267,157
Previous $33,000
703.03%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding SMMT
# of Institutions
233Shares Held
83.1MCall Options Held
1.66MPut Options Held
2.56M-
Baker Bros. Advisors LP New York, NY24.4MShares$438 Million4.83% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$209 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$142 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.56MShares$118 Million0.01% of portfolio
-
State Street Corp Boston, MA5.6MShares$100 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $3.61B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...